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Receptor or 
Family* Symbols Expression Major Functions
Disease 
Associations Target Genes
Estrogen-related 
receptors*
ERRα/NR3B1; 
ERRβ/NR3B2; 
ERRγ/NR3B3 
All major systems with specific isoforms 
showing peaks of expression in metabolic 
tissues (ERRα and ERRβ) and the CNS 
(ERRγ)
Structurally homologous to estrogen 
receptors; bind EREs but not activated 
by estrogens; modulate the expression 
of enzymes involved in adipogenesis, 
energy metabolism, and synthesis of 
lipids, eicosanoids, and steroids 
Bone, 
metabolic, 
deafness
↑ VEGF, PDK4, PLIN1, RB1CC1, BSP, 
CYP11A1, CYP27A1, HK2, PLSCR2, 
VLDLR, TFF1 (ERRα); CDKN1A (ERRβ); 
HK2, PLSCR2, VLDLR, CYP27A1, 
CDKN1A, CDKN1B, PDK4 (ERRγ) 
Steroidogenic 
factor-1
SF-1/NR5A1 Adrenal gland, hypothalamus, ovaries, and 
testes
Regulates mammalian sexual 
development; controls differentiation of 
steroidogenic tissues
Endocrine, 
metabolic
↑ STAR, CYP11A1, HS3DB2, INHA, AMH, 
CYP19A1
Retinoic acid 
receptor-related 
orphan receptors*
RORα/NR1F1; 
RORβ/NR1F2; 
RORγ/NR1F3
Many systems with peaks in the brain, 
testis, and skeletal muscle (RORα); GI tract, 
metabolic, and immune systems (RORγ); 
CNS (RORβ)
RORα and RORβ have roles in circadian 
rhythm and cell survival; RORγ is 
involved in thymocyte development and 
homeostasis; melatonin activates RORα
NA ↑ IL6, IL17A, CYP19A1, CYP7B1, 
SREBF1, APOC3, ARNTL1, CLOCK, 
CRY1, NPAS2, FGB, REV-ERBA, AFP, 
SULT1E1 (RORα); ARNTL1(RORβ); 
ARNTL1 (RORγ); ↓ OCN (RORα)
Hepatocyte nuclear 
factor 4 receptors*
HNF4α/NR2A1; 
HNF4β/NR2A2; 
HNF4γ/NR2A3
Peaks in the GI tract, WAT, and pancreas 
(HNF4α); GI tract and CNS (HNF4γ); liver, 
kidney, stomach, intestine, lung, ovaries, 
and testis (HNF4β)
Required for establishing and 
maintaining hepatocyte differentiation. 
HNF4α constitutively binds fatty acids
Metabolic ↑ LPIN1, SLC25A20, ABCC6, LIPC, 
COPA, HDAC6, RBKS, ERBB3, NGEF, 
ANXA4, LEAP2, EPO, G6PC (HNF4α)
Growth factor-
inducible immediate 
early gene nur/77-
like receptor
Nur77/NR4A1 All major systems with peaks in the aorta, 
adrenal gland, olfactory bulb, testes, lung, 
and skeletal muscle
Apoptotic signaling in thymocytes 
and tumor cells; signaling in the 
hypothalamic-pituitary axis.
Cancer ↑ APOA5, SERPINA3, TCL1A, INSL3, 
UCP3, CD36, ADIPOR2, SLC2A4, CAV3, 
POMC, HSSD3B2, FABP5, GJA1, TLL1, 
WISP2, IKBKE
Nur-related protein 1 NURR1/NR4A2 All major systems with peaks in the adrenal 
gland, aorta, brown adipose tissue, and 
the CNS (cerebelllum, cerebrum, corpus 
striatum, olfactory bulb, hypothalamus, and 
pituitary gland)
Expression is induced in response 
to various stress stimuli and growth 
factors; contributes to development of 
dopaminergic neurons.
Neurological, 
cardiovascular
↑ INSL3, TH, FABP5, SLC18A2, SLC6A3, 
DLK1, PTPRU, KLH1, IKBKE; ↓ IL1B, IL6, 
IL8, CCL2, CCL3, CCL4, TNFA, INOS
Neuron-derived 
orphan receptor 1
NOR1/NR4A3 All major systems with peaks in the CNS 
(cerebelllum, cerebrum, corpus striatum, 
olfactory bulb, hypothalamus, and pituitary 
gland)
Expression is induced in response 
to various stress stimuli and growth 
factors; signaling roles in multiple 
tissues, including the hypothalamic-
pituitary axis
Cancer ↑ INSL3, FABP5, CCND1, CCND2, IKBKE
Rev-ERBα Rev-ERBα/
NR1D1
CNS, endocrine, GI, reproductive, and 
cardiopulmonary systems; metabolic tissues 
(peaks in testis and skeletal muscle)
Rev-ERBα has roles in circadian 
rhythm in many processes, including 
adipogenesis. It is activated by heme as 
an inverse agonist
Neurological ↑ CYP7A, NFKBIA; ↓ ARNTL1, 
SERPINE1, APOA1, APOCIII, NR1D1, 
AFP
Rev-ERBβ Rev-ERBβ/
NR1D2
Most systems, with peaks in the CNS, 
including the hypothalamus, spinal cord, 
olfactory bulb, corpus striatum, cerebrum, 
and cerebellum
Rev-ERBβ has roles in circadian 
rhythm in many processes, including 
adipogenesis; heme activates Rev-
ERBβ by inverse agonist
NA ↑ SREBF1, CYP7A; ↓ ARNTL1, APOCIII, 
NR1D1, AFP
Chicken upstream 
ovalbumin promoter 
transcription factor II
COUP-TFII/
NR2F2
CNS, endocrine, metabolic, GI, immune, 
reproductive, cardiovascular, respiratory, 
and musculoskeletal systems
Roles in angiogenesis, establishing vein 
identity, vascular remodeling, and heart 
development
NA ↑ ANGPT1; ↓ ACOX1, CEBPA
Chicken upstream 
ovalbumin promoter 
transcription factor I
COUP-TFI/
NR2F1
CNS, endocrine, metabolic, GI, immune, 
reproductive, cardiovascular, respiratory, 
and musculoskeletal systems
Varied roles in the development of the 
peripheral nervous system, such as 
early regionalization of the neocortex, 
differentiation of subplate neurons, and 
guidance of thalamocortical axons
NA ↑ PCK1, PTH1R, CYP7A1, CYP11B2; ↓ 
LTF, LHCGR, APOA1, PENK, PPARA, 
SERPINC1, EPO, ACADL, NR0B1, OXT, 
OTC
V-erbA related 
protein
EAR2/NR2F6 Most major systems with peaks in the colon, 
gall bladder, kidney, and aorta
Functions include negative regulation of 
renin gene transcription and neuronal 
development
Cancer ↓ REN, LHCGR, ALDH2
Liver receptor 
homolog-1
LRH-1/NR5A2 Primarily in the GI system (duodenum, 
jejunum, ileum, colon, gall bladder), liver, 
and ovaries; also expressed during early 
embryonic development
Regulates genes involved in steroid, 
bile acid, and cholesterol homeostasis; 
drives rexprogramming of somatic cells 
to iPS cells.
NA ↑ POU5F1, NANOG, TBX3, KLF2, KLF5, 
RBP4, CYP17A1, CYP11A1, CYP7A1, 
CYP8B1, ABCB11, APOM, FAS
Testicular orphan 
receptors*
TR2/NR2C1; 
TR4/NR2C2
All major systems with peaks in the testis Negative modulators that suppress the 
transcriptional activity of other members 
of the NR superfamily
NA ↑ POU5F1, NANOG, (TR2); ↑ POU5F1, 
NANOG, APOE, PCK2, CD36, LHCGR, 
BCL2, OXT (TR4); ↓ GATA1, HBB (TR2 
and TR4)
Dosage-sensitive 
sex reversal-
adrenal hypoplasia 
congenita critical 
region on the X 
chromosome, gene 1
DAX1/NR0B1 Primarily in reproductive tissues (ovary, 
testis, uterus), endocrine tissues 
(adrenal gland), and CNS (pituitary and 
hypothalamus)
Lacks a DBD; inhibits the activity of 
other NRs by heterodimerization; 
involved in controlling development of 
the hypothalamic-pituitary axis, gonadal 
development, and sex determination
Reproductive, 
endocrine
↓ P450C17 CYP19A1, MIS, STAR, 
AKR1B7 [SF-1]
Germ cell nuclear 
factor
GCNF/NR6A1 Low levels in most systems with peaks 
in the testes; expressed during early and 
midgestation development in the embryo
Transcriptional repressor that is 
an essential factor in vertebrate 
embryogenesis
NA ↓ POU5F1, NANOG, PPARD, TDGF1, 
TDGF3, PRM1, PRM2, BMP15, GDF9, 
CYP26A1,TDGF1
Small heterodimeric 
partner
SHP/NR0B2 Primarily in endocrine (adrenal, pancreas), 
GI (stomach, duodenum, ileum, colon 
and gall bladder), metabolic (liver, 
kidney), reproductive (ovary and testis), 
cardiopulmonary (heart and lung), and CNS 
(cerebrum) organs
Lacks a DBD; functions as a 
corepressor to inhibit the activity of NRs 
and other signaling pathways; involved 
in the regulation of cholesterol, lipid, and 
glucose metabolism.
Metabolic ↓ PLIN1 [ERRα]; ABCG1 [LXRα]; CYP7A1 
[LRH-1]; INOS, PTGS2 [IL-1β]; AGT 
[HNF4α]
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Nuclear receptors (NRs) are a superfamily of transcription factors regulated by the direct binding of endogenous, dietary, clinical, and xenobiotic ligands. NRs are defined by the 
presence of conserved zinc finger DNA- and/or ligand-binding regions, and they interact with a group of diverse factors named coregulators (i.e., coactivators and corepressors) 
to orchestrate programs of gene expression in specific tissues.
In this SnapShot, we present information on a subgroup of the NRs called the orphan nuclear receptors. The cognate ligands for orphan receptors are either unknown or their 
physiological roles are not well characterized. The table here describes the major functions of these receptors, where they are expressed, their known target genes, and diseases 
associated with their abnormal activity. Symbols are given for the receptors as familiar symbol/Nuclear Receptor Nomenclature Committee name. Although human symbols are 
shown for the target genes of these receptors, regulation may have been demonstrated in human, mouse, or rat cells or tissues. In some cases, subfamily members that are 
encoded by distinct genes are discussed collectively. However, each receptor has specific contributions to the endocrine signaling axis in question. Certain NRs, such as DAX1 
and SHP, decrease transcription of a particular target gene by repressing the activity of another NR or signaling pathway. In these cases, the direct target of the NR is given in 
brackets in the far-right column. For example, DAX1 inhibits SHF-1 activation of ARKR1B7.
Additional information, such as knockout phenotypes, transcriptomics, and cistromics, is available at the Nuclear Receptor Signaling Atlas (NURSA) website Molecule Pages 
(http://www.nursa.org) and in the references below. Specific literature on diseases associated with these receptors is at the Diseases and Phenotypes section of the NURSA 
Molecule Pages (http://www.nursa.org). For relative expression levels in specific tissues, see http://www.nursa.org/datasets.cfm?doi=10.1621/datasets.02001 and Bookout et al. 
(2006). The ordering of receptors in the chart is based on visits to the NURSA Molecule Pages from May 2009–May 2010.
Abbreviations
AML, acute myeloid leukemia; DBD, DNA-binding domain; CNS, central nervous system; DEHA, Bis(2-ethylhexyl) adipate; DEHP, Bis(2-ethylhexyl) phthalate; ERE, estrogen 
response element; GI, gastrointestinal; FAs, fatty acids; iPS, induced pluripotent stem cells; NA, not available; PCBs, polychlorinated biphenyls, PUFAs, polyunsaturated fatty 
acids; WAT, white adipose tissue.
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